首页 > 最新文献

Interactive cardiovascular and thoracic surgery最新文献

英文 中文
Editorial: looking for the best treatment of bicuspid aortic valves. 社论:寻找治疗双尖瓣主动脉瓣的最佳方法。
IF 1.6 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac253
Ruggero De Paulis
{"title":"Editorial: looking for the best treatment of bicuspid aortic valves.","authors":"Ruggero De Paulis","doi":"10.1093/icvts/ivac253","DOIUrl":"10.1093/icvts/ivac253","url":null,"abstract":"","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":1.6,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33504489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic wrapping is life-saving in high-risk acute aortic dissection and intramural haematoma. 主动脉包裹术是挽救高危急性主动脉夹层和壁内血肿的重要手段。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac254
Thierry Carrel, Juri Sromicki, Martin Schmiady, Raed Aser, Ahmed Ouda, Paul Robert Vogt

Aortic wrapping is a controversial repair in patients presenting with acute type A aortic dissection or intramural haematoma, but this method may be a potential alternative to medical treatment or conventional repair in patients aged >80 years and in those presenting with prohibitive co-morbidities such as stroke, circulatory collapse, full oral anticoagulation with the last generation drugs. We report on 5 high-risk and/or patients over 80 years who received external aortic wrapping with or without cardiopulmonary bypass during the last 18 months. All survived the procedure and could be extubated early postoperatively. No patient remained on the intensive care longer than 2 days and all were discharged without additional complications. Postoperative radiological control was acceptable and no patient had any new aortic event up to 18 months postoperatively.

对于急性a型主动脉夹层或壁内血肿患者,主动脉包裹术是一种有争议的修复方法,但对于年龄>80岁的患者,以及那些有中风、循环衰竭、全口服抗凝等禁忌性合并症的患者,这种方法可能是药物治疗或传统修复的潜在替代方法。我们报告了5例80岁以上的高危和/或患者在过去18个月内接受了外主动脉包裹术,伴或不伴体外循环。所有患者均存活,术后早期可拔管。所有患者均未在重症监护室停留超过2天,出院时均无其他并发症。术后放射学控制是可接受的,术后18个月没有患者出现任何新的主动脉事件。
{"title":"Aortic wrapping is life-saving in high-risk acute aortic dissection and intramural haematoma.","authors":"Thierry Carrel,&nbsp;Juri Sromicki,&nbsp;Martin Schmiady,&nbsp;Raed Aser,&nbsp;Ahmed Ouda,&nbsp;Paul Robert Vogt","doi":"10.1093/icvts/ivac254","DOIUrl":"https://doi.org/10.1093/icvts/ivac254","url":null,"abstract":"<p><p>Aortic wrapping is a controversial repair in patients presenting with acute type A aortic dissection or intramural haematoma, but this method may be a potential alternative to medical treatment or conventional repair in patients aged >80 years and in those presenting with prohibitive co-morbidities such as stroke, circulatory collapse, full oral anticoagulation with the last generation drugs. We report on 5 high-risk and/or patients over 80 years who received external aortic wrapping with or without cardiopulmonary bypass during the last 18 months. All survived the procedure and could be extubated early postoperatively. No patient remained on the intensive care longer than 2 days and all were discharged without additional complications. Postoperative radiological control was acceptable and no patient had any new aortic event up to 18 months postoperatively.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A word to the wise …. 给智者的一句话....
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac252
Augusto D'Onofrio, Gino Gerosa
We read with interest Dr. David’s commentary [1] about our recently published paper entitled ‘Transapical beating heart mitral valve repair versus conventional surgery: a propensity-matched study’ [2]. We would like to clarify some aspects that in our opinion are crucial. We are afraid that Dr. David missed one of the key points of our study that, despite its intrinsic limitations that limit the generalizability of our results, shows that in patients with favourable anatomy (prolapse of the P2 segment), there seem to be no differences in terms of freedom from recurrent mitral regurgitation and of freedom from reoperation. Therefore, despite the worse outcomes in the overall population (this is what Dr. David refers to in his commentary), in well-selected patients, transapical beating heart mitral valve repair with neochords implantation (NC) provides similar outcomes to conventional surgery up to 5 years. We respectfully disagree with Dr. David when he states that NC should be selected in inoperable patients only after excluding the feasibility of a transcatheter Mitraclip (Abbott laboratories, Chicago, IL, USA). There are no data supporting this statement since there are no studies comparing NC and Mitraclip. However, in a recently published article about 100 NC patients with 5-year follow-up (including technical and patient-selection learning curves), we found an incidence of reoperation and of severe mitral regurgitation (MR), in patients with favourable anatomy, of 14.7% and 14.7%, respectively [3]. On the other hand, in the EVEREST-II study (therefore in highly selected patients), rates of reoperation and 3+ or 4+ MR at 5 years in the percutaneous repair group were 43% and 19%, respectively [4]. Noteworthy, 3+ and 4+ MR do not include moderate MR but only moderate– severe and severe MR and also, the EVEREST-II included both degenerative and functional MR. Another important aspect to consider is that so far over 100,000 patients over a 17-year period have been treated with Mitraclip, demonstrating the perseverance of our interventional cardiology colleagues (and some surgeons) that, despite the poor initial outcomes of this procedure, have worked to transform a suboptimal conventional surgical procedure (edge to edge with no annular stabilization) into a successful microinvasive alternative, optimizing technology, technique and patient selection [5, 6]. Meanwhile, NC procedures have been performed only in 1000 patients and we are still using the first-generation device. There are still many aspects that may be improved in order to achieve better results. We certainly agree that conventional surgery so far provides unsurpassed optimal outcomes for degenerative MR, especially if performed in high-volume centres and by highly committed surgeons or, even better, by world-recognized Masters as Dr. David. His results are impressive but the real world is a different thing and such numbers are difficult to replicate. The truth is that not all tennis
{"title":"A word to the wise ….","authors":"Augusto D'Onofrio,&nbsp;Gino Gerosa","doi":"10.1093/icvts/ivac252","DOIUrl":"https://doi.org/10.1093/icvts/ivac252","url":null,"abstract":"We read with interest Dr. David’s commentary [1] about our recently published paper entitled ‘Transapical beating heart mitral valve repair versus conventional surgery: a propensity-matched study’ [2]. We would like to clarify some aspects that in our opinion are crucial. We are afraid that Dr. David missed one of the key points of our study that, despite its intrinsic limitations that limit the generalizability of our results, shows that in patients with favourable anatomy (prolapse of the P2 segment), there seem to be no differences in terms of freedom from recurrent mitral regurgitation and of freedom from reoperation. Therefore, despite the worse outcomes in the overall population (this is what Dr. David refers to in his commentary), in well-selected patients, transapical beating heart mitral valve repair with neochords implantation (NC) provides similar outcomes to conventional surgery up to 5 years. We respectfully disagree with Dr. David when he states that NC should be selected in inoperable patients only after excluding the feasibility of a transcatheter Mitraclip (Abbott laboratories, Chicago, IL, USA). There are no data supporting this statement since there are no studies comparing NC and Mitraclip. However, in a recently published article about 100 NC patients with 5-year follow-up (including technical and patient-selection learning curves), we found an incidence of reoperation and of severe mitral regurgitation (MR), in patients with favourable anatomy, of 14.7% and 14.7%, respectively [3]. On the other hand, in the EVEREST-II study (therefore in highly selected patients), rates of reoperation and 3+ or 4+ MR at 5 years in the percutaneous repair group were 43% and 19%, respectively [4]. Noteworthy, 3+ and 4+ MR do not include moderate MR but only moderate– severe and severe MR and also, the EVEREST-II included both degenerative and functional MR. Another important aspect to consider is that so far over 100,000 patients over a 17-year period have been treated with Mitraclip, demonstrating the perseverance of our interventional cardiology colleagues (and some surgeons) that, despite the poor initial outcomes of this procedure, have worked to transform a suboptimal conventional surgical procedure (edge to edge with no annular stabilization) into a successful microinvasive alternative, optimizing technology, technique and patient selection [5, 6]. Meanwhile, NC procedures have been performed only in 1000 patients and we are still using the first-generation device. There are still many aspects that may be improved in order to achieve better results. We certainly agree that conventional surgery so far provides unsurpassed optimal outcomes for degenerative MR, especially if performed in high-volume centres and by highly committed surgeons or, even better, by world-recognized Masters as Dr. David. His results are impressive but the real world is a different thing and such numbers are difficult to replicate. The truth is that not all tennis ","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observed versus expected morbidity and mortality in patients undergoing mitral valve repair. 观察到的与预期的二尖瓣修复患者的发病率和死亡率。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac241
Paige Newell, Richard Tartarini, Sameer Hirji, Morgan Harloff, Siobhan McGurk, Olena Cherkasky, Tsuyoshi Kaneko

Objectives: Mitral valve repair (MVP) is the gold standard treatment for degenerative mitral regurgitation. With the expansion of transcatheter technologies, this study compares the outcome of MVP in low-risk and non-low-risk patients to serve as a benchmark.

Methods: This retrospective, single-institution study examined all patients who underwent MVP for primary mitral regurgitation from 2005 to 2018. Patients were stratified into 2 risk categories: low-risk [Society of Thoracic Surgeons (STS) Predicted Risk of Mortality (STS-PROM) ≤2%] and non-low risk (STS-PROM > 2% or age > 75), with a subgroup of very low risk (STS-PROM ≤1%, age <75).

Results: A total of 1207 patients were included, and 1053 patients were classified as low risk and 154 as non-low risk. The non-low-risk group was significantly older, more likely to be female, and had a higher comorbidity burden than the low-risk group (all P < 0.01). For the low-risk group, the observed-to-expected (O:E) STS mortality ratio was 0.4 and the composite morbidity and mortality ratio was 0.6, whereas for the non-low risk, the O:E mortality was 1.5 and the composite morbidity and mortality was 0.9. When the subgroup of very low-risk group was assessed, the mortality O:E ratio was 0.

Conclusions: The observed composite morbidity and mortality of patients undergoing MVP were persistently lower in low-risk patients, mainly driven by the very low-risk group. The excellent outcome of MVP in low-risk patients should be validated on a national level to determine how transcatheter technologies can be utilized in these patients.

目的:二尖瓣修复(MVP)是退行性二尖瓣反流的金标准治疗方法。随着经导管技术的扩展,本研究比较低风险和非低风险患者的MVP结果,作为基准。方法:这项回顾性的单机构研究调查了2005年至2018年所有因原发性二尖瓣反流接受MVP治疗的患者。将患者分为低危[胸外科学会(STS)预测死亡风险(STS- prom)≤2%]和非低危(STS- prom > 2%或年龄> 75岁)2类,并分为极低危亚组(STS- prom≤1%,年龄)。结果:共纳入1207例患者,其中1053例为低危,154例为非低危。非低危组年龄明显大于低危组,女性居多,合并症负担明显高于低危组(均P)。结论:低危组观察到的MVP患者综合发病率和死亡率持续较低,主要由极低危组驱动。MVP在低风险患者中的出色结果应在国家层面进行验证,以确定如何在这些患者中使用经导管技术。
{"title":"Observed versus expected morbidity and mortality in patients undergoing mitral valve repair.","authors":"Paige Newell,&nbsp;Richard Tartarini,&nbsp;Sameer Hirji,&nbsp;Morgan Harloff,&nbsp;Siobhan McGurk,&nbsp;Olena Cherkasky,&nbsp;Tsuyoshi Kaneko","doi":"10.1093/icvts/ivac241","DOIUrl":"https://doi.org/10.1093/icvts/ivac241","url":null,"abstract":"<p><strong>Objectives: </strong>Mitral valve repair (MVP) is the gold standard treatment for degenerative mitral regurgitation. With the expansion of transcatheter technologies, this study compares the outcome of MVP in low-risk and non-low-risk patients to serve as a benchmark.</p><p><strong>Methods: </strong>This retrospective, single-institution study examined all patients who underwent MVP for primary mitral regurgitation from 2005 to 2018. Patients were stratified into 2 risk categories: low-risk [Society of Thoracic Surgeons (STS) Predicted Risk of Mortality (STS-PROM) ≤2%] and non-low risk (STS-PROM > 2% or age > 75), with a subgroup of very low risk (STS-PROM ≤1%, age <75).</p><p><strong>Results: </strong>A total of 1207 patients were included, and 1053 patients were classified as low risk and 154 as non-low risk. The non-low-risk group was significantly older, more likely to be female, and had a higher comorbidity burden than the low-risk group (all P < 0.01). For the low-risk group, the observed-to-expected (O:E) STS mortality ratio was 0.4 and the composite morbidity and mortality ratio was 0.6, whereas for the non-low risk, the O:E mortality was 1.5 and the composite morbidity and mortality was 0.9. When the subgroup of very low-risk group was assessed, the mortality O:E ratio was 0.</p><p><strong>Conclusions: </strong>The observed composite morbidity and mortality of patients undergoing MVP were persistently lower in low-risk patients, mainly driven by the very low-risk group. The excellent outcome of MVP in low-risk patients should be validated on a national level to determine how transcatheter technologies can be utilized in these patients.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung transplantation in patients with a history of anatomical native lung resection. 有解剖性原生肺切除史的患者进行肺移植。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac256
Ilker Iskender, Ylenia Pecoraro, Paula Moreno Casado, Bartosz Kubisa, Marco Schiavon, Eleonora Faccioli, Jonas Ehrsam, Francesco Damarco, Mario Nosotti, Ilhan Inci, Federico Venuta, Dirk Van Raemdonck, Laurens J Ceulemans

Objectives: History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify indications, intraoperative approach and outcome in these challenging cases in a retrospective multicentre cohort analysis.

Methods: Members of the ESTS Lung Transplantation Working Group were invited to submit data on patients undergoing LTx after a previous anatomical native lung resection between January 2005 and July 2020. The primary end point was overall survival (Kaplan-Meier estimation).

Results: Out of 2690 patients at 7 European centres, 26 (1%) patients (14 males; median age 33 years) underwent LTx after a previous anatomical lung resection. The median time from previous lung resection to LTx was 12 years. The most common indications for lung resection were infections (n = 17), emphysema (n = 5), lung tumour (n = 2) and others (n = 2). Bronchiectasis (cystic fibrosis or non-cystic fibrosis related) was the main indication for LTx (n = 21), followed by COPD (n = 5). Two patients with a previous pneumonectomy underwent contralateral single LTx and 1 patient with a previous lobectomy had ipsilateral single LTx. The remaining 23 patients underwent bilateral LTx. Clamshell incision was performed in 12 (46%) patients. Moreover, LTx was possible without extracorporeal life support in 13 (50%) patients. 90-Day mortality was 8% (n = 2) and the median survival was 8.7 years.

Conclusions: The history of anatomical lung resection is rare in LTx candidates. The majority of patients are young and diagnosed with bronchiectasis. Although the numbers were limited, survival after LTx in patients with previous anatomical lung resection, including pneumonectomy, is comparable to reported conventional LTx for bronchiectasis.

目的:解剖肺切除并发肺移植(LTx)的病史。我们的目的是在回顾性多中心队列分析中确定这些具有挑战性病例的适应症、术中入路和结果。方法:邀请ESTS肺移植工作组成员提交2005年1月至2020年7月间解剖性原生肺切除术后行LTx患者的数据。主要终点为总生存期(Kaplan-Meier估计)。结果:在7个欧洲中心的2690例患者中,26例(1%)患者(14例男性;中位年龄33岁),先前解剖性肺切除术后行LTx。从上一次肺切除术到LTx的中位时间为12年。肺切除术最常见的适应症是感染(17例)、肺气肿(5例)、肺肿瘤(2例)和其他(2例)。支气管扩张(囊性纤维化或非囊性纤维化相关)是LTx的主要适应症(n = 21),其次是COPD (n = 5)。2例既往行肺切除术的患者行对侧单侧LTx, 1例既往行肺叶切除术的患者行同侧单侧LTx。其余23例患者行双侧LTx。12例(46%)患者行翻盖切口。此外,13例(50%)患者在没有体外生命支持的情况下可以进行LTx。90天死亡率为8% (n = 2),中位生存期为8.7年。结论:肺解剖切除史在LTx患者中是罕见的。大多数患者是年轻人,诊断为支气管扩张。尽管数量有限,但先前解剖性肺切除术(包括全肺切除术)患者的LTx生存率与报道的常规支气管扩张LTx相当。
{"title":"Lung transplantation in patients with a history of anatomical native lung resection.","authors":"Ilker Iskender,&nbsp;Ylenia Pecoraro,&nbsp;Paula Moreno Casado,&nbsp;Bartosz Kubisa,&nbsp;Marco Schiavon,&nbsp;Eleonora Faccioli,&nbsp;Jonas Ehrsam,&nbsp;Francesco Damarco,&nbsp;Mario Nosotti,&nbsp;Ilhan Inci,&nbsp;Federico Venuta,&nbsp;Dirk Van Raemdonck,&nbsp;Laurens J Ceulemans","doi":"10.1093/icvts/ivac256","DOIUrl":"https://doi.org/10.1093/icvts/ivac256","url":null,"abstract":"<p><strong>Objectives: </strong>History of anatomical lung resection complicates lung transplantation (LTx). Our aim was to identify indications, intraoperative approach and outcome in these challenging cases in a retrospective multicentre cohort analysis.</p><p><strong>Methods: </strong>Members of the ESTS Lung Transplantation Working Group were invited to submit data on patients undergoing LTx after a previous anatomical native lung resection between January 2005 and July 2020. The primary end point was overall survival (Kaplan-Meier estimation).</p><p><strong>Results: </strong>Out of 2690 patients at 7 European centres, 26 (1%) patients (14 males; median age 33 years) underwent LTx after a previous anatomical lung resection. The median time from previous lung resection to LTx was 12 years. The most common indications for lung resection were infections (n = 17), emphysema (n = 5), lung tumour (n = 2) and others (n = 2). Bronchiectasis (cystic fibrosis or non-cystic fibrosis related) was the main indication for LTx (n = 21), followed by COPD (n = 5). Two patients with a previous pneumonectomy underwent contralateral single LTx and 1 patient with a previous lobectomy had ipsilateral single LTx. The remaining 23 patients underwent bilateral LTx. Clamshell incision was performed in 12 (46%) patients. Moreover, LTx was possible without extracorporeal life support in 13 (50%) patients. 90-Day mortality was 8% (n = 2) and the median survival was 8.7 years.</p><p><strong>Conclusions: </strong>The history of anatomical lung resection is rare in LTx candidates. The majority of patients are young and diagnosed with bronchiectasis. Although the numbers were limited, survival after LTx in patients with previous anatomical lung resection, including pneumonectomy, is comparable to reported conventional LTx for bronchiectasis.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/06/24/ivac256.PMC9583932.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33500609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repair of coronary artery ostium with a ring-shaped bovine pericardial patch. 环形牛心包补片修复冠状动脉开口。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac251
Dong Zhang, Gui-Jun Zhu, Xiang-Yang Wei, Bin Li, Jie Hu, Wei-Guo Ma, Xing-Peng Chen

As an approach to coronary artery ostial injury in type A aortic dissection and infective endocarditis, we describe a technique of coronary ostial repair using a ring-shaped bovine pericardial patch. The inner and outer rims of the patch were sutured to the involved coronary ostium (to close the ostial tear) and to the aortic wall (to cover the sinus), respectively. Four patients were successfully managed and computed tomographic coronary arteriogram at follow-up showed patent coronary ostia and arteries. The favourable preliminary results imply that this technique is a simple, safe and effective approach to coronary ostial repair in patients with type A aortic dissection or infective endocarditis.

作为A型主动脉夹层和感染性心内膜炎的冠状动脉口损伤的一种方法,我们描述了一种使用环形牛心包补片修复冠状动脉口的技术。将补片的内外缘分别缝合在受累的冠状动脉口(封闭口口撕裂)和主动脉壁(覆盖窦)上。4例患者治疗成功,随访时冠状动脉ct显示冠脉口和动脉未闭。初步结果表明,该技术对a型主动脉夹层或感染性心内膜炎患者的冠状动脉口修复是一种简单、安全、有效的方法。
{"title":"Repair of coronary artery ostium with a ring-shaped bovine pericardial patch.","authors":"Dong Zhang,&nbsp;Gui-Jun Zhu,&nbsp;Xiang-Yang Wei,&nbsp;Bin Li,&nbsp;Jie Hu,&nbsp;Wei-Guo Ma,&nbsp;Xing-Peng Chen","doi":"10.1093/icvts/ivac251","DOIUrl":"https://doi.org/10.1093/icvts/ivac251","url":null,"abstract":"<p><p>As an approach to coronary artery ostial injury in type A aortic dissection and infective endocarditis, we describe a technique of coronary ostial repair using a ring-shaped bovine pericardial patch. The inner and outer rims of the patch were sutured to the involved coronary ostium (to close the ostial tear) and to the aortic wall (to cover the sinus), respectively. Four patients were successfully managed and computed tomographic coronary arteriogram at follow-up showed patent coronary ostia and arteries. The favourable preliminary results imply that this technique is a simple, safe and effective approach to coronary ostial repair in patients with type A aortic dissection or infective endocarditis.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33503606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AVNeo improves early haemodynamics in regurgitant bicuspid aortic valves compared to aortic valve repair. 与主动脉瓣修复术相比,AVNeo 可改善反流性双尖瓣主动脉瓣的早期血液动力学状况。
IF 1.6 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac226
Anatol Prinzing, Johannes Böhm, Konstantinos Sideris, Keti Vitanova, Rüdiger Lange, Markus Krane

Objectives: Calcified or fibrotic cusps in patients with bicuspid aortic valves and aortic regurgitation complicate successful aortic valve (AV)-repair. Aortic valve neocuspidization (AVNeo) with autologous pericardium offers an alternative treatment to prosthetic valve replacement. We compared patients with regurgitant bicuspid valves undergoing AV-repair or AVNeo.

Methods: We retrospectively analysed patients with regurgitant bicuspid valves undergoing AV-repair or AVNeo. We focused on residual regurgitation, pressure gradients and effective orifice area, determined preoperatively and at discharge.

Results: AV-repair was performed in 61 patients (mean age: 43.2 ± 11.3 years) and AVNeo in 22 (45.7 ± 14.1). Prior to the operation patients of the AV-repair group showed severe regurgitation in 38 cases (62.3%) and moderate in 23 (37.6%); in the AVNeo group, all patients exhibited severe regurgitation. Postoperatively, 57 patients (93.4%) patients had no or mild regurgitation after AV-repair and 21 (95.4%) after AVNeo. In AVNeo-patients, peak (10.6 ± 3.1 mmHg vs 22.7 ± 11 mmHg, P< 0.001) and mean pressure gradients (5.9 ± 2 mmHg vs 13.8 ± 7.3 mmHg, P < 0.001) were significantly lower and the orifice area significantly larger (2.9 ± 0.8 cm2 vs 1.9 ± 0.7 cm2, P < 0.001) compared to repair.

Conclusions: Compared to AV-repair, patients AVNeo showed lower mean pressure gradients and larger orifice areas at discharge. The functional result was not different.

目的:二尖瓣主动脉瓣和主动脉瓣反流患者的瓣尖钙化或纤维化会使主动脉瓣(AV)的成功修复复杂化。使用自体心包进行主动脉瓣新瓣膜化(AVNeo)是替代人工瓣膜置换术的一种治疗方法。我们对接受主动脉瓣修复术或 AVNeo 术的双尖瓣反流患者进行了比较:我们对接受房室修复术或 AVNeo 手术的二尖瓣反流患者进行了回顾性分析。我们重点研究了术前和出院时测定的残余反流、压力梯度和有效瓣口面积:61名患者(平均年龄为43.2 ± 11.3岁)接受了房室修复术,22名患者(45.7 ± 14.1岁)接受了AVNeo术。手术前,房室修复组患者中有 38 例(62.3%)表现为严重反流,23 例(37.6%)表现为中度反流;在 AVNeo 组中,所有患者均表现为严重反流。术后,57 名患者(93.4%)在房室修复术后没有反流或反流程度较轻,21 名患者(95.4%)在房室奈何术后没有反流或反流程度较轻。与修复术相比,AVNeo 患者的峰值(10.6 ± 3.1 mmHg vs 22.7 ± 11 mmHg,P< 0.001)和平均压力梯度(5.9 ± 2 mmHg vs 13.8 ± 7.3 mmHg,P< 0.001)明显降低,孔口面积明显增大(2.9 ± 0.8 cm2 vs 1.9 ± 0.7 cm2,P< 0.001):结论:与 AV 修复术相比,AVNeo 患者出院时平均压力梯度较低,管口面积较大。功能结果没有差异。
{"title":"AVNeo improves early haemodynamics in regurgitant bicuspid aortic valves compared to aortic valve repair.","authors":"Anatol Prinzing, Johannes Böhm, Konstantinos Sideris, Keti Vitanova, Rüdiger Lange, Markus Krane","doi":"10.1093/icvts/ivac226","DOIUrl":"10.1093/icvts/ivac226","url":null,"abstract":"<p><strong>Objectives: </strong>Calcified or fibrotic cusps in patients with bicuspid aortic valves and aortic regurgitation complicate successful aortic valve (AV)-repair. Aortic valve neocuspidization (AVNeo) with autologous pericardium offers an alternative treatment to prosthetic valve replacement. We compared patients with regurgitant bicuspid valves undergoing AV-repair or AVNeo.</p><p><strong>Methods: </strong>We retrospectively analysed patients with regurgitant bicuspid valves undergoing AV-repair or AVNeo. We focused on residual regurgitation, pressure gradients and effective orifice area, determined preoperatively and at discharge.</p><p><strong>Results: </strong>AV-repair was performed in 61 patients (mean age: 43.2 ± 11.3 years) and AVNeo in 22 (45.7 ± 14.1). Prior to the operation patients of the AV-repair group showed severe regurgitation in 38 cases (62.3%) and moderate in 23 (37.6%); in the AVNeo group, all patients exhibited severe regurgitation. Postoperatively, 57 patients (93.4%) patients had no or mild regurgitation after AV-repair and 21 (95.4%) after AVNeo. In AVNeo-patients, peak (10.6 ± 3.1 mmHg vs 22.7 ± 11 mmHg, P&lt; 0.001) and mean pressure gradients (5.9 ± 2 mmHg vs 13.8 ± 7.3 mmHg, P &lt; 0.001) were significantly lower and the orifice area significantly larger (2.9 ± 0.8 cm2 vs 1.9 ± 0.7 cm2, P &lt; 0.001) compared to repair.</p><p><strong>Conclusions: </strong>Compared to AV-repair, patients AVNeo showed lower mean pressure gradients and larger orifice areas at discharge. The functional result was not different.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":1.6,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/ec/ivac226.PMC9615556.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33439789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic remodelling and late outcomes following thoracic endovascular repair with a bare-metal stent distal extension among patients with complicated type-B aortic dissection. 复杂b型主动脉夹层患者经远端延伸裸金属支架胸腔内修复后的主动脉重构和晚期预后
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac244
Isaac Wamala, Mir Timo Zadegh Nazari-Shafti, Roland Heck, Adam Penkalla, Matteo Montagner, Steven J Staffa, Volkmar Falk, Semih Buz

Objectives: The goal of this study was to describe the factors affecting mid and late aortic remodelling following thoracic endovascular aortic repair with the PETTICOAT (Provisional Extension To Induce Complete Attachment) technique among patients with complicated acute or subacute type B aortic dissection.

Methods: A retrospective single-centre study that evaluates clinical and morphological outcomes among 65 consecutive patients. The area and diameter of the true and false lumen, overall aortic diameter and false lumen perfusion were evaluated.

Results: Concomitant direct visceral artery stenting was successfully conducted in 32 (49%) patients. There was one (1.5%) postoperative stroke; three (4.6%) patients developed spinal cord ischaemia; two (3%) patients suffered retrograde type A dissection; and two (3%) patients had mesenteric ischaemia, despite successful reperfusion, that required a bowel resection. Median postoperative follow-up was 63.1 (interquartile range, 32.1- 91.8) months. The probability of survival was 96.9% [95% confidence interval (CI) 88.3%-99.2%] at 30 days, 93.9% (95% CI 84.4%-97.6%) at 1 year, 78.0 (95% CI 64.2%-87.0%) at 5 years and 72.8% (95% CI at 57.9%-83.2%) at 10 years postoperatively. There was a statistically significant postoperative increase in true-lumen area, diameter and true-lumen index in all five aortic levels measured. Complete false lumen (FL) thrombosis at the coeliac trunk, renal arteries and aortic bifurcation levels was observed in 47%, 15% and 24% of patients at midterm (6-15 months) and in 29%, 21% and 29% on late (later than 21 months) computed tomography angiograms (CTA). Persistent false lumen (FL) perfusion at the coeliac level on midterm CTA was associated with a larger extent of late aortic growth (P = 0.042) and was, in the majority of cases, caused by iliac re-entries either alone (28.57) or in combination with visceral and lumbar (28.57%) or distal aortic (10.71%) re-entries. A larger abdominal aortic diameter at midterm was associated with an increased probability of distal aortic reinterventions (hazard ratio 7.26, 95% CI 2.41-21.9, P < 0.001).

Conclusions: Persistent FL perfusion of the distal aorta at midterm following TEVAR with the PETTICOAT technique among patients with acute and subacute type B dissection is caused mainly by iliac, visceral, lumber and distal aorta re-entries. Patients with persistent FL perfusion have an increased risk of aortic aneurysmal growth at late follow-up.

目的:本研究的目的是描述在并发急性或亚急性B型主动脉夹层患者中,应用PETTICOAT(临时延伸诱导完全附着)技术进行胸腔血管内主动脉修复术后中晚期主动脉重构的影响因素。方法:回顾性单中心研究,评估65例连续患者的临床和形态学结果。评估真、假腔面积、直径、主动脉总直径及假腔灌注情况。结果:32例(49%)患者成功行直接内脏动脉支架植入术。术后卒中1例(1.5%);3例(4.6%)患者发生脊髓缺血;2例(3%)患者发生逆行A型夹层;2例(3%)患者有肠系膜缺血,尽管再灌注成功,但需要肠切除术。术后中位随访时间为63.1个月(四分位数间距为32.1 ~ 91.8个月)。术后30天生存率为96.9%[95%可信区间(CI) 88.3% ~ 99.2%], 1年生存率为93.9% (95% CI 84.4% ~ 97.6%), 5年生存率为78.0 (95% CI 64.2% ~ 87.0%), 10年生存率为72.8% (95% CI 57.9% ~ 83.2%)。术后真腔面积、直径和真腔指数均有统计学意义的增加。在中期(6-15个月),47%、15%和24%的患者在腹腔干、肾动脉和主动脉分叉水平观察到完全假腔(FL)血栓形成,在晚期(21个月以上)ct血管造影(CTA)中观察到29%、21%和29%的患者出现完全性假腔血栓形成。中期CTA显示腹腔水平持续假腔(FL)灌注与较大程度的晚期主动脉生长相关(P = 0.042),并且在大多数情况下,由髂再入引起,单独(28.57%)或合并内脏和腰椎(28.57%)或远端主动脉(10.71%)再入。中期腹主动脉直径增大与主动脉远端再介入的可能性增加相关(风险比7.26,95% CI 2.41-21.9, P)。结论:急性和亚急性B型夹层患者采用PETTICOAT技术进行TEVAR后中期远端主动脉持续FL灌注主要是由髂、内脏、腰椎和远端主动脉再进入引起的。持续FL灌注的患者在后期随访时动脉瘤生长的风险增加。
{"title":"Aortic remodelling and late outcomes following thoracic endovascular repair with a bare-metal stent distal extension among patients with complicated type-B aortic dissection.","authors":"Isaac Wamala,&nbsp;Mir Timo Zadegh Nazari-Shafti,&nbsp;Roland Heck,&nbsp;Adam Penkalla,&nbsp;Matteo Montagner,&nbsp;Steven J Staffa,&nbsp;Volkmar Falk,&nbsp;Semih Buz","doi":"10.1093/icvts/ivac244","DOIUrl":"https://doi.org/10.1093/icvts/ivac244","url":null,"abstract":"<p><strong>Objectives: </strong>The goal of this study was to describe the factors affecting mid and late aortic remodelling following thoracic endovascular aortic repair with the PETTICOAT (Provisional Extension To Induce Complete Attachment) technique among patients with complicated acute or subacute type B aortic dissection.</p><p><strong>Methods: </strong>A retrospective single-centre study that evaluates clinical and morphological outcomes among 65 consecutive patients. The area and diameter of the true and false lumen, overall aortic diameter and false lumen perfusion were evaluated.</p><p><strong>Results: </strong>Concomitant direct visceral artery stenting was successfully conducted in 32 (49%) patients. There was one (1.5%) postoperative stroke; three (4.6%) patients developed spinal cord ischaemia; two (3%) patients suffered retrograde type A dissection; and two (3%) patients had mesenteric ischaemia, despite successful reperfusion, that required a bowel resection. Median postoperative follow-up was 63.1 (interquartile range, 32.1- 91.8) months. The probability of survival was 96.9% [95% confidence interval (CI) 88.3%-99.2%] at 30 days, 93.9% (95% CI 84.4%-97.6%) at 1 year, 78.0 (95% CI 64.2%-87.0%) at 5 years and 72.8% (95% CI at 57.9%-83.2%) at 10 years postoperatively. There was a statistically significant postoperative increase in true-lumen area, diameter and true-lumen index in all five aortic levels measured. Complete false lumen (FL) thrombosis at the coeliac trunk, renal arteries and aortic bifurcation levels was observed in 47%, 15% and 24% of patients at midterm (6-15 months) and in 29%, 21% and 29% on late (later than 21 months) computed tomography angiograms (CTA). Persistent false lumen (FL) perfusion at the coeliac level on midterm CTA was associated with a larger extent of late aortic growth (P = 0.042) and was, in the majority of cases, caused by iliac re-entries either alone (28.57) or in combination with visceral and lumbar (28.57%) or distal aortic (10.71%) re-entries. A larger abdominal aortic diameter at midterm was associated with an increased probability of distal aortic reinterventions (hazard ratio 7.26, 95% CI 2.41-21.9, P < 0.001).</p><p><strong>Conclusions: </strong>Persistent FL perfusion of the distal aorta at midterm following TEVAR with the PETTICOAT technique among patients with acute and subacute type B dissection is caused mainly by iliac, visceral, lumber and distal aorta re-entries. Patients with persistent FL perfusion have an increased risk of aortic aneurysmal growth at late follow-up.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33478734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Use of virtual reality for procedural planning of transcatheter aortic valve replacement. 虚拟现实技术在经导管主动脉瓣置换术中的应用。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac248
Xavier Ruyra, Eduard Permanyer, Marina Huguet, Giuliana Maldonado

This study sought to evaluate the impact of virtual reality (VR) tools in procedural planning of transcatheter aortic valve replacement. A prospective study involving 11 patients referred for transcatheter aortic valve replacement was conducted. A multidetector computed tomography was used to acquire and segment the anatomy of the access route and landing zone. From the information obtained with the multidetector computed tomography in DICOM format, we built a virtual platform (VisuaMed, Techer Team, Valencia, Spain) that contains all the clinical information of the patients and a virtualized model of their anatomy. Wearing VR devices, the professional was able to 'walk inside' the anatomy in an interactive and immersive way. Decisions after the evaluation of routine clinical images were compared with those after experience with VR models and intraprocedural findings.

本研究旨在评估虚拟现实(VR)工具在经导管主动脉瓣置换术程序规划中的影响。对11例经导管主动脉瓣置换术患者进行前瞻性研究。使用多探测器计算机断层扫描来获取和分割通道和着陆区的解剖结构。根据DICOM格式的多探测器计算机断层扫描获得的信息,我们建立了一个虚拟平台(VisuaMed, Techer Team, Valencia, Spain),其中包含了患者的所有临床信息和他们的解剖虚拟模型。戴上虚拟现实设备,这位专业人士能够以一种互动和沉浸式的方式“走进”解剖结构。将常规临床图像评估后的决定与VR模型经验和术中发现后的决定进行比较。
{"title":"Use of virtual reality for procedural planning of transcatheter aortic valve replacement.","authors":"Xavier Ruyra,&nbsp;Eduard Permanyer,&nbsp;Marina Huguet,&nbsp;Giuliana Maldonado","doi":"10.1093/icvts/ivac248","DOIUrl":"https://doi.org/10.1093/icvts/ivac248","url":null,"abstract":"<p><p>This study sought to evaluate the impact of virtual reality (VR) tools in procedural planning of transcatheter aortic valve replacement. A prospective study involving 11 patients referred for transcatheter aortic valve replacement was conducted. A multidetector computed tomography was used to acquire and segment the anatomy of the access route and landing zone. From the information obtained with the multidetector computed tomography in DICOM format, we built a virtual platform (VisuaMed, Techer Team, Valencia, Spain) that contains all the clinical information of the patients and a virtualized model of their anatomy. Wearing VR devices, the professional was able to 'walk inside' the anatomy in an interactive and immersive way. Decisions after the evaluation of routine clinical images were compared with those after experience with VR models and intraprocedural findings.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/49/ivac248.PMC9639804.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33493854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing. 分期单孔胸腔镜R2交感神经切开术是一种可重复、安全、有效的治疗方法。
4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2022-10-10 DOI: 10.1093/icvts/ivac257
Emma van der Weijde, Michiel Kuijpers, Wobbe Bouma, Massimo A Mariani, Theo J Klinkenberg

Objectives: Our goal was to investigate the safety, feasibility, success rate, complication rate and side effects of staged single-port thoracoscopic R2 sympathicotomy in the treatment of severe facial blushing. Facial blushing is considered a benign condition; however, severe facial blushing can have a major impact on quality of life. When nonsurgical options such as medication and psychological treatments offer no or insufficient relief, surgical treatment with thoracoscopic sympathicotomy should be considered.

Methods: All patients who underwent a staged thoracoscopic sympathicotomy at level R2 for severe facial blushing between January 2016 and September 2021 were included. Clinical and surgical data were prospectively collected and analysed.

Results: A total of 16 patients with low operative risk (American Society of Anesthesiologists class 1) were treated. No major perioperative complications were encountered. One patient experienced postoperative unilateral Horner's syndrome that resolved completely after 1 week. Two patients experienced compensatory hyperhidrosis. The success rate was 100%. One patient experienced a slight recurrence of blushing symptoms after 3 years that did not interfere with their quality of life. All patients were satisfied with the results and had no regrets of having undergone the procedure.

Conclusions: Staged single-port thoracoscopic R2 sympathicotomy is a reproducible, safe and highly effective surgical treatment option with low compensatory hyperhidrosis rates and the potential to significantly improve quality of life in carefully selected patients suffering from severe facial blushing. We would like to increase awareness among healthcare professionals for debilitating facial blushing and suggest timely referral for surgical treatment.

目的:探讨分期单孔胸腔镜R2交感神经切开术治疗重度面红症的安全性、可行性、成功率、并发症发生率及不良反应。面部脸红被认为是一种良性状况;然而,严重的面部脸红会对生活质量产生重大影响。当药物和心理治疗等非手术治疗不能缓解或不能充分缓解时,应考虑胸腔镜下交感神经切开术的手术治疗。方法:纳入2016年1月至2021年9月期间因严重面部脸红接受分期胸腔镜交感神经切开术的所有患者。前瞻性地收集和分析临床和手术资料。结果:共收治低手术风险患者16例(美国麻醉医师学会1级)。围手术期无重大并发症。1例患者术后出现单侧霍纳综合征,1周后完全消退。2例患者出现代偿性多汗症。成功率为100%。一名患者在3年后经历了轻微的脸红症状复发,但没有影响他们的生活质量。所有患者对结果都很满意,没有后悔接受手术。结论:分期单孔胸腔镜R2交感神经切开术是一种可重复、安全、高效的手术治疗选择,代偿性多汗症发生率低,对精心挑选的严重面部发红患者有显著改善生活质量的潜力。我们希望提高医疗保健专业人员对使人衰弱的面部脸红的认识,并建议及时转诊进行手术治疗。
{"title":"Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing.","authors":"Emma van der Weijde,&nbsp;Michiel Kuijpers,&nbsp;Wobbe Bouma,&nbsp;Massimo A Mariani,&nbsp;Theo J Klinkenberg","doi":"10.1093/icvts/ivac257","DOIUrl":"https://doi.org/10.1093/icvts/ivac257","url":null,"abstract":"<p><strong>Objectives: </strong>Our goal was to investigate the safety, feasibility, success rate, complication rate and side effects of staged single-port thoracoscopic R2 sympathicotomy in the treatment of severe facial blushing. Facial blushing is considered a benign condition; however, severe facial blushing can have a major impact on quality of life. When nonsurgical options such as medication and psychological treatments offer no or insufficient relief, surgical treatment with thoracoscopic sympathicotomy should be considered.</p><p><strong>Methods: </strong>All patients who underwent a staged thoracoscopic sympathicotomy at level R2 for severe facial blushing between January 2016 and September 2021 were included. Clinical and surgical data were prospectively collected and analysed.</p><p><strong>Results: </strong>A total of 16 patients with low operative risk (American Society of Anesthesiologists class 1) were treated. No major perioperative complications were encountered. One patient experienced postoperative unilateral Horner's syndrome that resolved completely after 1 week. Two patients experienced compensatory hyperhidrosis. The success rate was 100%. One patient experienced a slight recurrence of blushing symptoms after 3 years that did not interfere with their quality of life. All patients were satisfied with the results and had no regrets of having undergone the procedure.</p><p><strong>Conclusions: </strong>Staged single-port thoracoscopic R2 sympathicotomy is a reproducible, safe and highly effective surgical treatment option with low compensatory hyperhidrosis rates and the potential to significantly improve quality of life in carefully selected patients suffering from severe facial blushing. We would like to increase awareness among healthcare professionals for debilitating facial blushing and suggest timely referral for surgical treatment.</p>","PeriodicalId":13621,"journal":{"name":"Interactive cardiovascular and thoracic surgery","volume":"35 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/bb/ivac257.PMC9596140.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33512314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interactive cardiovascular and thoracic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1